Akiko Shimamura, MD, PhD

Director, Bone Marrow Failure and Myelodysplastic Syndrome Programs, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-919-6109
Appointment Phone: 844-222-9991
Fax: 617-730-0934
Preferred Contact Method: email

General

Treatment Centers
Disciplines
Pediatric Hematology/Oncology
Clinical Interests
Bone marrow failure, Aplastic anemia, Myelodysplastic syndromes (MDS), Cancer predisposition

Location

Boston Children's Hospital
300 Longwood Ave.
Boston, MA  02115

Background

Board Certifications
Pediatric Hematology/Oncology, 1997
Fellowships
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 1997
Residency
Johns Hopkins Hospital, Pediatrics, 1994
Medical School
University of Rochester School of Medicine, 1991
Biography

Children with rare disorders, such as bone marrow failure and MDS, deserve the same level of medical care and the same chance to live a healthy life as children with more common disorders. We are striving to identify the causes of bone marrow failure and MDS to develop better treatments for these disorders. We partner with the patient, the family, and the referring physicians to work together as a team to develop and implement an individualized medical plan. My research spans basic scientific studies and clinical studies with the goal of improving the diagnosis and treatment of patients with bone marrow failure and MDS. Our patients benefit from access to the exciting scientific and clinical advances and cutting edge technologies developed by researchers at Harvard.

Video: Meet Akiko Shimamura

Akiko Shimamura, MD, PhD, discusses our personalized approach to treatment and care for children with bone marrow failure and myelodysplastic syndromes (MDS) at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.